Accéder au contenu
Merck
  • Tumour microenvironments induce expression of urokinase plasminogen activator receptor (uPAR) and concomitant activation of gelatinolytic enzymes.

Tumour microenvironments induce expression of urokinase plasminogen activator receptor (uPAR) and concomitant activation of gelatinolytic enzymes.

PloS one (2014-08-27)
Synnøve Magnussen, Elin Hadler-Olsen, Nadezhda Latysheva, Emma Pirila, Sonja E Steigen, Robert Hanes, Tuula Salo, Jan-Olof Winberg, Lars Uhlin-Hansen, Gunbjørg Svineng
RÉSUMÉ

The urokinase plasminogen activator receptor (uPAR) is associated with poor prognosis in oral squamous cell carcinoma (OSCC), and increased expression of uPAR is often found at the invasive tumour front. The aim of the current study was to elucidate the role of uPAR in invasion and metastasis of OSCC, and the effects of various tumour microenvironments in these processes. Furthermore, we wanted to study whether the cells' expression level of uPAR affected the activity of gelatinolytic enzymes. The Plaur gene was both overexpressed and knocked-down in the murine OSCC cell line AT84. Tongue and skin tumours were established in syngeneic mice, and cells were also studied in an ex vivo leiomyoma invasion model. Soluble factors derived from leiomyoma tissue, as well as purified extracellular matrix (ECM) proteins, were assessed for their ability to affect uPAR expression, glycosylation and cleavage. Activity of gelatinolytic enzymes in the tissues were assessed by in situ zymography. We found that increased levels of uPAR did not induce tumour invasion or metastasis. However, cells expressing low endogenous levels of uPAR in vitro up-regulated uPAR expression both in tongue, skin and leiomyoma tissue. Various ECM proteins had no effect on uPAR expression, while soluble factors originating from the leiomyoma tissue increased both the expression and glycosylation of uPAR, and possibly also affected the proteolytic processing of uPAR. Tumours with high levels of uPAR, as well as cells invading leiomyoma tissue with up-regulated uPAR expression, all displayed enhanced activity of gelatinolytic enzymes. Although high levels of uPAR are not sufficient to induce invasion and metastasis, the activity of gelatinolytic enzymes was increased. Furthermore, several tumour microenvironments have the capacity to induce up-regulation of uPAR expression, and soluble factors in the tumour microenvironment may have an important role in the regulation of posttranslational modification of uPAR.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Milieu RPMI-1640, With L-glutamine and sodium bicarbonate, liquid, sterile-filtered, suitable for cell culture
Sigma-Aldrich
Sérum de veau fœtal, non-USA origin, sterile-filtered, suitable for cell culture
Sigma-Aldrich
Puromycine dihydrochloride from Streptomyces alboniger, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
DL-Dithiothréitol solution, BioUltra, for molecular biology, ~1 M in H2O
Supelco
DL-Dithiothréitol solution, 1 M in H2O
Sigma-Aldrich
G 418 disulfate salt solution, 50 mg/mL in H2O, 0.1 μm filtered, BioReagent, suitable for cell culture
Sigma-Aldrich
Cocktail d′inhibiteurs de protéases SIGMAFAST, comprimés, sans EDTA, for use in purification of Histidine-tagged proteins
Sigma-Aldrich
BIS-TRIS, ≥98.0% (titration)
Sigma-Aldrich
Puromycine dihydrochloride, Ready Made Solution, from Streptomyces alboniger, 10 mg/mL in H2O, suitable for cell culture
Sigma-Aldrich
Puromycine dihydrochloride from Streptomyces alboniger, ≥98% (HPLC), powder
Sigma-Aldrich
Luminol, 97%
SAFC
BIS-TRIS
Sigma-Aldrich
Luminol, ≥97% (HPLC)
Sigma-Aldrich
BIS-TRIS, BioUltra, ≥99.0% (NT)
Sigma-Aldrich
BIS-TRIS, BioPerformance Certified, suitable for cell culture, suitable for insect cell culture, ≥98.0%
Sigma-Aldrich
BIS-TRIS, BioXtra, ≥98.0% (titration)
SAFC
BIS-TRIS
Sigma-Aldrich
Anticorps monoclonal de souris anti-IgG de chèvre/mouton−peroxydase antibody produced in mouse, clone GT-34, purified from hybridoma cell culture
Sigma-Aldrich
MISSION® esiRNA, targeting human PLAUR
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Plaur